Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.28% were unchanged Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.91% rising 0.42% to 4,419.15 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.48% rising 0.44% to 35,084.53. Johnson & Johnson closed $1.47 short of its 52-week high ($173.65), which the company reached on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -2.06% rose 3.57% to $382.17, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.40% fell 1.79% to $76.93, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.30% fell 0.63% to $42.79. Trading volume (4.2 M) remained 2.2 million below its 50-day average volume of 6.4 M.